REDUCE allows you to iterate through your data, building your result step-by-step, in the same way a loop operates in a programming language. Instead of scattering your intermediate calculations ...

Abstract: Recently, deep learning has been introduced to automate network management to reduce human costs. However, the amount of log data obtained from the large-scale network is huge, and ...

Transferring data from your PC to your phone in 2025 is easier than ever—and that’s great because we’re all dealing with (and moving around) more data across more devices than ever before. Software ...

OpenAI has rolled out ChatGPT Atlas, a new AI-powered browser for macOS users, integrating ChatGPT's capabilities directly into web browsing. This free tool allows users to access AI assistance across ...

Apple’s AppMigrationKit, in beta for iOS 26.1 and iPadOS 26.1, lets developers include app data when migrating between Apple and Android. It doesn’t support iOS-to-iOS, macOS, or visionOS transfers.

Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

A few days ago, Apple published documentation for a new framework designed to simplify the transfer of third-party app data between iOS and Android. Here’s how it’ll work. AppMigrationKit to allow ‘a ...

Abstract: Source-free cross-modal knowledge transfer is a crucial yet challenging task, which aims to transfer knowledge from one source modality (e.g., RGB) to the target modality (e.g., depth or ...

Switching from an iPhone to an Android phone is more common today, but it’s not always easy. One of the biggest concerns is how to move your WhatsApp data, including chats, media, and documents. Many ...

Sometimes you have no other choice but to share a large document from your Mac to a PC over a network. Here's how to get file sharing working between macOS Tahoe and Windows. Apple's ecosystem is a ...

Early clinical and preclinical data support darlifarnib’s potential to enhance clinical benefit of PI3Kα-, KRAS- and tyrosine kinase inhibitors 50% objective response rate and 80% disease control rate ...